C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 311/19 (2006.01) A61K 31/18 (2006.01) A61P 9/00 (2006.01) C07C 311/29 (2006.01) C07C 311/42 (2006.01) C07C 311/46 (2006.01) C07C 311/47 (2006.01) C07D 213/42 (2006.01) C07D 295/12 (2006.01)
Patent
CA 2644783
The present invention provides a compound of formula (I): said compound is inhibitor of MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-9, and/or MMP-12 and/or MMP-13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-9, and/or MMP-12 and/or MMP-13. Finally, the present invention also provides a pharmaceutical composition.
La présente invention concerne un composé de formule (I) : Ledit composé est un inhibiteur de la MMP-9 et/ou de la MMP-12 et/ou de la MMP-13, et il peut ainsi être utilisé pour le traitement d'une maladie ou d'une affection caractérisée par une activité anormale de la MMP-9 et/ou de la MMP-12 et/ou de la MMP-13. En conséquence, le composé de formule (I) peut être utilisé pour le traitement d'une maladie ou d'une affection induite par la MMP-9 et/ou par la MMP-12 et/ou par la MMP-13. Finalement, la présente invention concerne également une composition pharmaceutique.
Grob Jonathan E.
Honda Ayako
Leutert Thomas
Pusateri Erin E.
Tommasi Ruben Alberto
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Selective hydroxamate based mmp inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective hydroxamate based mmp inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective hydroxamate based mmp inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1911420